Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
- NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
- As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Smartphones and IVD: Early, But Getting There
The current developments, product launches and company plans in IVD testing on smartphone platforms has been detailed by Kalorama Information in a recent report by Kalorama’s Rob Camp: https://www.kaloramainformation.com/Smartphone-Based-IVD-Products-Trends-Potential-12019398/ We summarize some of the findings of our study here. This represents a fraction of the findings of the report: The techniques that can most successfully harness […]
CVS-Aetna Merger and Walgreens-LabCorp Partnership: Assessing The Impact
In separate moves, the two largest pharmacy retailers dramatically changed their businesses. CVS merged with healthcare insurance giant Aetna. But Walgreens also had news – the drugstore giant merged with clinical reference company LabCorp to put an announced 600 consumer testing stations in its retail stores. Both are a good sign for the market for […]
Moving the Ball Forward on EMR Connectivity for IVD Devices
Authored by Julie Kirkwood, Kalorama Information Correspondent Until surprisingly recently, the connections between laboratory instruments and laboratory computers were based on standards developed in the 1990s. For example, one of the standards, ASTM E1394 (later revised and renamed CLSI LIS2) dates back to 1997, the year before Google was invented, when dial-up modems were still used […]
PAMA brings huge changes to lab price testing, faces resistance from ACLA
We at Kalorama Information have just released the Eleventh Edition of our flagship publication,The Worldwide Market for In Vitro Diagnostics. This report has been updated for two decades, keeping readers informed about developments in all areas of the IVD industry, around the world, in one volume. At 1,800 pages, the report provides market size estimates and projections […]
Next Generation Sequencing Continues to Make Strides: Neonatal Screening, Onco-genomics, Infectious Disease Dx, and More
Next-generation sequencing (NGS) in diagnostics is rapidly growing, having made great strides since the conclusion of the Human Genome Project fifteen years ago. Increasingly rapid and effective testing capabilities for hereditary diseases, cancers, cardiac and respiratory conditions, neurodegenerative disorders, and even infectious disease, are either on the horizon or have arrived. The promise of DNA […]
Kalorama To Present IVD Market Findings at BIOMEDevice
In many ways, the IVD market of today does not resemble the market five years ago. 2018 appears to be the year where a number of trends that had been discussed began to gel. With that in mind, Kalorama Information will be on hand for UBM’s BIOMedDevice Convention in San Jose, CA next month. In […]
China’s IVD Market: Attractive Target for Surplus Growth
China’s IVD market reached $3,200 million in 2017, in line with growth estimates published by Kalorama and elsewhere, and the fast pace of market growth is expected to continue. Supporting growth will be a modernizing healthcare infrastructure and steady migration from manual to automated processes. This was the conclusion of Kalorama Information’s recent report, IVD in […]
Four Things to Know About The Monoclonal Antibodies – “mAbs” Market
Kalorama Information notes 4 trends in monoclonal antibodies (mAbs) – large protein molecules produced by white blood cells that seek out and destroy harmful foreign substances – topped $100 billion in 2017, according to Kalorama Information What’s Trending in Monoclonal Antibodies, examines the several types of monoclonal antibodies on the market and in development, looking at […]
Severe Flu Season Provides an Opportunity for Molecular POC
It’s late January, 2018. It’s the centenary of the opening salvos of the “Spanish” Flu Pandemic, the unsung (and misnomered) villain of the later days of The Great War. With cases on the rise right now, the 2017-’18 flu season has yet to reach its peak[1], surpassing that of the 2012-’13 season, and young people […]
Top 10 Companies in Liquid Biopsy Detailed in New Report
New York City-based healthcare market researcher Kalorama Information details the top 10 liquid biopsy companies and their activities in a new report. The market, Kalorama says, is heterogeneous and very fragmented, with many companies commercializing various liquid biopsy diagnostic products and developing new ones for a broad range of applications. But a few top competitors […]